PL3385386T6 - Biosyntetyczny klaster genów karymycyny - Google Patents

Biosyntetyczny klaster genów karymycyny

Info

Publication number
PL3385386T6
PL3385386T6 PL16880824T PL16880824T PL3385386T6 PL 3385386 T6 PL3385386 T6 PL 3385386T6 PL 16880824 T PL16880824 T PL 16880824T PL 16880824 T PL16880824 T PL 16880824T PL 3385386 T6 PL3385386 T6 PL 3385386T6
Authority
PL
Poland
Prior art keywords
carrimycin
gene cluster
biosynthetic gene
biosynthetic
cluster
Prior art date
Application number
PL16880824T
Other languages
English (en)
Other versions
PL3385386T3 (pl
Inventor
Yiguang Wang
Yang Jang
Xiaofeng Zhao
Weiqing He
Jianlu Dai
Original Assignee
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Fuyang Pharmaceutical Technology Co., Ltd. filed Critical Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Publication of PL3385386T3 publication Critical patent/PL3385386T3/pl
Publication of PL3385386T6 publication Critical patent/PL3385386T6/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01064Testosterone 17-beta-dehydrogenase (NADP+) (1.1.1.64)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01188Prostaglandin-F synthase (1.1.1.188)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/01Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
    • C12Y103/01008Acyl-CoA dehydrogenase (NADP+) (1.3.1.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/01Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01013Glycine N-acyltransferase (2.3.1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/02Thioester hydrolases (3.1.2)
    • C12Y301/02007Glutathione thiolesterase (3.1.2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/02003Dihydroorotase (3.5.2.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL16880824T 2015-12-31 2016-11-24 Biosyntetyczny klaster genów karymycyny PL3385386T6 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201511028754.9A CN105505954B (zh) 2015-12-31 2015-12-31 可利霉素生物合成基因簇
PCT/CN2016/107039 WO2017114034A1 (zh) 2015-12-31 2016-11-24 可利霉素生物合成基因簇
EP16880824.4A EP3385386B3 (en) 2015-12-31 2016-11-24 Carrimycin biosynthetic gene cluster

Publications (2)

Publication Number Publication Date
PL3385386T3 PL3385386T3 (pl) 2020-11-30
PL3385386T6 true PL3385386T6 (pl) 2021-04-19

Family

ID=55714247

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16880824T PL3385386T6 (pl) 2015-12-31 2016-11-24 Biosyntetyczny klaster genów karymycyny

Country Status (20)

Country Link
US (1) US10858659B2 (pl)
EP (1) EP3385386B3 (pl)
JP (1) JP6882330B2 (pl)
KR (1) KR20180093083A (pl)
CN (2) CN107868789B (pl)
AU (1) AU2016383270A1 (pl)
BR (1) BR112018013309A2 (pl)
CA (1) CA3009706A1 (pl)
CL (1) CL2018001796A1 (pl)
CO (1) CO2018007130A2 (pl)
DK (1) DK3385386T6 (pl)
ES (1) ES2812256T7 (pl)
MY (1) MY193028A (pl)
PE (1) PE20190221A1 (pl)
PH (1) PH12018501393A1 (pl)
PL (1) PL3385386T6 (pl)
RU (1) RU2719189C2 (pl)
UA (1) UA124058C2 (pl)
WO (1) WO2017114034A1 (pl)
ZA (1) ZA201804397B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106916835B (zh) * 2015-12-24 2022-08-12 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN107868789B (zh) 2015-12-31 2020-11-17 沈阳福洋医药科技有限公司 可利霉素生物合成基因簇
AU2018247555B2 (en) 2017-04-06 2024-04-18 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors
CN111349595A (zh) * 2018-12-20 2020-06-30 沈阳福洋医药科技有限公司 一种螺旋霉素产生菌、可利霉素产生菌、构建方法、应用及提高产物产量的方法
CN111197019B (zh) * 2020-01-10 2022-04-15 安徽大学 一种通过糖多孢红霉菌sace_1906基因途径提高红霉素产量的方法
CN114517175B (zh) * 2020-11-20 2024-04-09 上海医药工业研究院 基因工程菌及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068189A (en) * 1988-05-13 1991-11-26 Eli Lilly And Company Recombinant dna vectors encoding a 4"-o-isovaleryl acylase derived from a carbomycin biosynthetic gene, designated care, for use in streptomyces and other organisms
CA2197160C (en) 1996-02-22 2007-05-01 Stanley Gene Burgett Platenolide synthase gene
CN1058295C (zh) 1997-06-03 2000-11-08 中国医学科学院医药生物技术研究所 一种利用基因工程技术制造生技霉素的方法
US7109019B2 (en) * 1999-01-06 2006-09-19 The Regents Of The University Of California Gene cluster for production of the enediyne antitumor antibiotic C-1027
JP2004049100A (ja) 2002-07-19 2004-02-19 Meiji Seika Kaisha Ltd ミデカマイシンの生合成遺伝子
CA2394849A1 (en) 2002-07-24 2004-01-24 Ian Kerr Improved prefabricated door frame and door
CN1169947C (zh) 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN1237976C (zh) 2003-12-23 2006-01-25 沈阳同联集团有限公司 必特螺旋霉素及其在抗感染性疾病中的应用
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
CN101914482B (zh) * 2010-07-23 2012-07-04 中国医学科学院医药生物技术研究所 一株异戊酰螺旋霉素i组分高含量、高产量基因工程菌
CN102115757B (zh) * 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
CN103820474A (zh) * 2012-11-16 2014-05-28 中国医药集团总公司四川抗菌素工业研究所 一种多烯多醇大环内脂类化合物的生物合成基因簇
CN107868789B (zh) * 2015-12-31 2020-11-17 沈阳福洋医药科技有限公司 可利霉素生物合成基因簇

Also Published As

Publication number Publication date
RU2719189C2 (ru) 2020-04-17
CN107868789B (zh) 2020-11-17
CO2018007130A2 (es) 2018-07-19
CN105505954B (zh) 2019-01-22
RU2018125487A (ru) 2020-01-31
ES2812256T7 (es) 2021-09-22
JP2019500903A (ja) 2019-01-17
US10858659B2 (en) 2020-12-08
CL2018001796A1 (es) 2018-09-28
EP3385386A4 (en) 2018-10-10
JP6882330B2 (ja) 2021-06-02
ZA201804397B (en) 2019-09-25
CA3009706A1 (en) 2017-07-06
PE20190221A1 (es) 2019-02-13
KR20180093083A (ko) 2018-08-20
CN107868789A (zh) 2018-04-03
AU2016383270A1 (en) 2018-07-26
PL3385386T3 (pl) 2020-11-30
RU2018125487A3 (pl) 2020-02-14
MY193028A (en) 2022-09-23
BR112018013309A2 (pt) 2018-12-11
ES2812256T3 (es) 2021-03-16
PH12018501393A1 (en) 2019-02-27
WO2017114034A1 (zh) 2017-07-06
US20190093112A1 (en) 2019-03-28
EP3385386B1 (en) 2020-05-27
CN105505954A (zh) 2016-04-20
EP3385386A1 (en) 2018-10-10
EP3385386B3 (en) 2020-11-18
UA124058C2 (uk) 2021-07-14
DK3385386T3 (da) 2020-08-31
DK3385386T6 (da) 2021-02-08

Similar Documents

Publication Publication Date Title
HK1256688A1 (zh) 核酸酶介導的dna組裝
IL284577A (en) Garden healing
GB201504223D0 (en) Biallelic genetic modification
EP3239298A4 (en) Gene knockout method
IL258149B (en) Aggregate galnac phosphoramidite
EP3194411A4 (en) Nucleotide analogs
IL257831A (en) Diplospore garden
PL3385386T6 (pl) Biosyntetyczny klaster genów karymycyny
EP3350191A4 (en) NUCLEOTIDE ANALOGS
IL249254A0 (en) Gene expression system
IL257500A (en) Altered cullin1 gene
SG11201708466VA (en) Incubation tray
EP3295959A4 (en) Cmlck gene introduction
EP3271462A4 (en) System for stable gene expression
GB201514420D0 (en) Bioreactor
GB201520827D0 (en) Bioreactor
GB201514734D0 (en) Mechanical bioreactor
GB201513151D0 (en) Functional gene replacement therapy
GB201608944D0 (en) Gene Tharapy
GB201518810D0 (en) Bioreactor
GB201517290D0 (en) Bioreactor
GB201507125D0 (en) Gene delivery
AU2015900904A0 (en) Vertical staircase - 2
AU363119S (en) Incubator